STOCKHOLM, SWEDEN--(Marketwire - January 12, 2009) -
Biovitrum's CEO Martin Nicklasson will give a company presentation
at
the 27th Annual J.P. Morgan Healthcare Conference being held
January
12-15, 2009, in San Francisco, USA.
The presentation is scheduled to take place on Wednesday January 14 at 4:00 p.m. (PST). A live webcast, as well as an archived, will be available via Biovitrums website at www.biovitrum.com. The presentation material will be available on www.biovitrum.com under the link presentations on the investor relations page.
About Biovitrum
Biovitrum is a pharmaceutical company with operations in Sweden and in the UK. The company markets a range of specialist pharmaceuticals. Using its expertise and experience Biovitrum takes scientific innovation all the way to the market and to specialist indication patients with significant medical need. Research expertise and capabilities include development and production of biotechnology therapeutics, as well as small molecule discovery and development. With revenues of approximately SEK 1.3 billion and around 500 employees, Biovitrum is a significant international specialty pharmaceutical player. Biovitrum's share is listed on the OMX Nordic Exchange in Stockholm. For more information go to www.biovitrum.com
This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Copyright © Hugin AS 2009. All rights reserved.
For more information please contact:
Biovitrum
Göran Arvidson
CFO
Phone: +46 8 697 23 68
